Sibanye Stillwater
SBSW
9.68
-0.33
-3.30%
Sibanye Stillwater
US · SBSW
#1774 by market cap
Listed 1970
9.68
-0.33
-3.30%
Live - 5344 symbols - heartbeat 151s ago
· 2026-10-08 08:35
Pre-market
9.67
-0.10%
After-hours
9.72
+0.41%
Overnight
9.79
+1.14%
- Market cap
- 6.85B
- P/E (TTM)i
- 7.96
- P/Bi
- 2.12
- EPSi
- -0.44
- Div yieldi
- 3.38%
- 52W posi
- 17%
Reader sentiment
Are you bullish or bearish on SBSW?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.49, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +15.65% YoY
Margins
- Gross margin
- 23.68%
- Operating margin
- 19.32%
- Net margin
- -3.99%
Key ratios & quality
- Enterprise valuei
- 33.09B
- Altman Z-Scorei
- 1.49
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 50.66B | 72.93B | 127.39B | 172.19B | 138.29B | 113.68B | 112.13B | 129.68B |
| Gross profit | 2.21B | 9.09B | 42.07B | 59.85B | 34.60B | 12.78B | 6.31B | 30.71B |
| Selling & admin expenses | 314.80M | 373.00M | 1.07B | 1.11B | 436.00M | 217.00M | 379.00M | 2.53B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 986.60M | 7.26B | 39.92B | 57.53B | 32.82B | 8.42B | 3.68B | 25.06B |
| Pretax profit | -1.44B | -1.30B | 35.48B | 47.56B | 27.90B | -39.85B | -4.21B | -411.00M |
| Tax | 1.08B | -1.73B | 4.86B | 13.76B | 8.92B | -2.42B | 1.50B | 4.33B |
| Net profit | -2.52B | 433.00M | 30.62B | 33.80B | 18.98B | -37.43B | -5.71B | -4.74B |
| Basic EPS | -4 | 0 | 43 | 46 | 26 | -53 | -10 | -7 |
| Diluted EPS | -4.40 | 0.08 | 42.20 | 45.16 | 26.00 | -53.36 | -10.32 | -7.32 |
| Line item | 2023-12 | 2024-06 | 2024-12 | 2025-06 | 2025-12 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | -- |
| Gross profit | -- | -- | -- | -- | -- | -- |
| Selling & admin expenses | -- | -- | -- | -- | -- | -- |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | -- | -- | -- | -- | -- | -- |
| Pretax profit | -- | -- | -- | -- | -- | -- |
| Tax | -- | -- | -- | -- | -- | -- |
| Net profit | -- | -- | -- | -- | -- | -- |
| Basic EPS | -- | -- | -- | -- | -- | -- |
| Diluted EPS | -- | -- | -- | -- | -- | -- |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 15.20B | 26.16B | 52.24B | 64.83B | 60.76B | 61.82B | 48.41B | 60.75B |
| Cash & ST investments | 2.55B | 5.62B | 20.24B | 30.29B | 26.08B | 25.56B | 16.05B | 17.18B |
| Inventory | 5.29B | 15.50B | 24.95B | 25.08B | 26.38B | 26.36B | 25.55B | 31.48B |
| Total assets | 84.92B | 101.07B | 134.10B | 152.99B | 166.63B | 142.94B | 138.09B | 149.74B |
| Total current liabilities | 14.63B | 14.33B | 17.49B | 20.54B | 20.22B | 36.41B | 20.95B | 34.16B |
| Short-term debt | 6.19B | 148.00M | 989.00M | 211.00M | 233.00M | 15.68B | 727.00M | 11.57B |
| Long-term debt | 18.32B | 23.70B | 17.50B | 20.19B | 22.61B | 24.95B | 41.14B | 31.86B |
| Total liabilities | 60,198,600,000.00 | 69,934,000,000.00 | 63,387,000,000.00 | 71,649,000,000.00 | 75,627,000,000.00 | 91,334,000,000.00 | 89,799,000,000.00 | 105,570,000,000.00 |
| Total equity | 24.72B | 31.14B | 70.72B | 81.35B | 91.00B | 51.61B | 48.29B | 44.17B |
| Retained earnings | -15.50B | -15.43B | 12.22B | 27.41B | 33.78B | -8.47B | -13.82B | -19.08B |
| Line item | 2023-12 | 2024-06 | 2024-12 | 2025-06 | 2025-12 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 61.82B | 51.53B | 48.41B | 60.37B | 60.75B | 63.94B |
| Cash & ST investments | 25.56B | 15.56B | 16.05B | 21.01B | 17.18B | 22.43B |
| Inventory | 26.36B | 25.87B | 25.55B | 28.34B | 31.48B | 31.83B |
| Total assets | 142.94B | 134.91B | 138.09B | 144.70B | 149.74B | 159.43B |
| Total current liabilities | 36.41B | 24.70B | 20.95B | 20.90B | 34.16B | 23.51B |
| Short-term debt | 15.68B | 4.89B | 727.00M | 460.00M | 11.57B | 414.00M |
| Long-term debt | 24.95B | 32.60B | 41.14B | 42.14B | 31.86B | 36.51B |
| Total liabilities | 91,334,000,000.00 | 88,371,000,000.00 | 89,799,000,000.00 | 100,354,000,000.00 | 105,570,000,000.00 | 100,259,000,000.00 |
| Total equity | 51.61B | 46.54B | 48.29B | 44.35B | 44.17B | 59.17B |
| Retained earnings | -8.47B | -13.99B | -13.82B | -17.41B | -19.08B | -5.05B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 12.20B | 9.46B | 27.15B | 32.26B | 15.54B | 7.10B | 10.11B | 21.41B |
| Depreciation & amortization | 6.61B | 7.21B | 7.59B | 8.29B | 7.09B | 10.01B | 8.81B | 9.37B |
| Free cash flow | 5.12B | 1.76B | 17.54B | 19.52B | -356.00M | -15.32B | -11.46B | 1.10B |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | 1.69B | -84.00M | -8.50B | 0 | 1.10B | 0 | 0 |
| Ending cash balance | 2.55B | 5.62B | 20.24B | 30.29B | 26.08B | 25.56B | 16.05B | 17.18B |
| Line item | 2023-12 | 2024-06 | 2024-12 | 2025-06 | 2025-12 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -- | -- | -- | -- | -- | -- |
| Depreciation & amortization | -- | -- | -- | -- | -- | -- |
| Free cash flow | -- | -- | -- | -- | -- | -- |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | -- | -- | -- | -- | -- | -- |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -10.47 | 0.23 | 59.73 | 44.54 | 21.90 | -55.21 | -15.74 | -12.38 |
| ROA %i | -3.11 | 0.07 | 24.93 | 23.03 | 11.51 | -24.40 | -5.19 | -3.59 |
| ROIC %i | -2.02 | 2.86 | 43.16 | 35.64 | 17.98 | -36.72 | -6.70 | -4.26 |
| 5-year avg ROE %i | 1.50 | -1.03 | 10.01 | 14.55 | 23.33 | 14.38 | 11.19 | -3.30 |
| EBIT margin %i | 2.25 | 1.65 | 29.69 | 28.64 | 21.72 | -33.02 | -0.85 | 2.55 |
| FCF / sales %i | 10.10 | 2.41 | 13.76 | 11.33 | -- | -- | -- | 0.85 |
| Current ratioi | 1.04 | 1.83 | 2.99 | 3.16 | 3.01 | 1.70 | 2.31 | 1.78 |
| Quick ratioi | 0.66 | 0.71 | 1.54 | 1.91 | 1.68 | 0.94 | 1.05 | 0.84 |
| Debt / assetsi | 28.86 | 23.86 | 13.95 | 13.45 | 13.83 | 28.69 | 30.46 | 29.32 |
| LT debt / equityi | 77.00 | 80.79 | 26.08 | 25.65 | 25.90 | 51.98 | 93.99 | 81.81 |
| Interest coveragei | 0.44 | 0.48 | 16.10 | 27.98 | 14.07 | -16.23 | -0.29 | 0.89 |
| Revenue CAGR (3Y) %i | 30.64 | 32.65 | 40.52 | 50.36 | 23.78 | -3.72 | -13.32 | -2.12 |
| Net income CAGR (3Y) %i | -- | -73.87 | -- | -- | 566.98 | -- | -- | -- |
| FCF CAGR (3Y) %i | 210.75 | 90.44 | -- | 56.24 | -- | -- | -- | -- |
| Line item | 2023-12 | 2024-06 | 2024-12 | 2025-06 | 2025-12 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -55.21 | -75.03 | -15.74 | -8.48 | -12.38 | 34.37 |
| ROA %i | -24.40 | -33.40 | -5.19 | -2.54 | -3.59 | 10.63 |
| ROIC %i | -36.72 | -50.38 | -6.70 | -2.31 | -4.26 | 19.92 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -33.02 | -49.53 | -0.85 | 2.45 | 2.55 | 19.19 |
| FCF / sales %i | -- | -- | -- | -- | 0.85 | 5.32 |
| Current ratioi | 1.70 | 2.09 | 2.31 | 2.89 | 1.78 | 2.72 |
| Quick ratioi | 0.94 | 1.04 | 1.05 | 1.52 | 0.84 | 1.35 |
| Debt / assetsi | 28.69 | 28.00 | 30.46 | 29.62 | 29.32 | 23.42 |
| LT debt / equityi | 51.98 | 75.77 | 93.99 | 105.02 | 81.81 | 68.77 |
| Interest coveragei | -16.23 | -19.56 | -0.29 | 0.77 | 0.89 | 8.98 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Diversified
- Rustenburg is the largest reported line at 24.13% of revenue, across 10 reported segments.
- No single line clears half of revenue; Marikana is next at 21.86%, spreading the business across more than one real driver.
Revenue breakdown most recent period
Business
Rustenburg24.13%
Marikana21.86%
US Operations20.91%
Driefontein9.72%
DRDGOLD7.04%
Beatrix4.84%
Kloof4.22%
Century zinc retreatment operation3.60%
Mimosa2.79%
Other0.90%
Region
Southern Africa (SA) Operations75.53%
United States (US)20.47%
Australia (AUS)3.60%
Europe (EU)0.40%
Quote time 2026-10-08 08:35:51 · For reference only, not investment advice and not tailored to your situation.